Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Conditions:   Acute Myeloid Leukemia;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm;   Acute Myeloid Leukemia With Myelodysplasia-Related Changes;   Therapy-Related Acute Myeloid Leukemia Interventions:   Drug: Azacitidine;   Procedure: Biospecimen Collection;   Procedure: Bone Marrow Aspiration;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Liposome-encapsulated Daunorubicin-Cytarabine;   Drug: Venetoclax Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials